Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II

Immunochemical and Mass-Spectrometry-Based Serum Hepcidin Assays for Iron Metabolism Disorders

(2010) J. J. C. Kroot et al.   CLINICAL CHEMISTRY

Iron Metabolism and Iron Chelation in Sickle Cell Disease

(2009) Patrick B. Walter et al.   ACTA HAEMATOLOGICA

Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells

(2009) T. Tanno et al.   BLOOD

SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression

(2009) K. Mleczko-Sanecka et al.   BLOOD

Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia

(2009) Igor Theurl et al.   BRITISH JOURNAL OF HAEMATOLOGY

Hepcidin targets ferroportin for degradation in hepatocytes

(2009) G. Ramey et al.   HAEMATOLOGICA

Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II

(2009) Klaus Schwarz et al.   NATURE GENETICS

Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I

(2008) H. Tamary et al.   BLOOD

Regulation of growth differentiation factor 15 expression by intracellular iron

(2008) S. Lakhal et al.   BLOOD

Forging a field: the golden age of iron biology

(2008) N. C. Andrews   BLOOD

Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBP 

(2008) J. P. Pinto et al.   BLOOD

Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency

(2008) Armin Finkenstedt et al.   BRITISH JOURNAL OF HAEMATOLOGY

Regulation of hepcidin: Insights from biochemical analyses on human serum samples

(2007) Erwin H.J.M. Kemna et al.   BLOOD CELLS MOLECULES AND DISEASES